✦ LIBER ✦

ChemInform Abstract: A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors.

✍ Scribed by Norikazu Ohtake; Toshiaki Mase; et al. et al.

Publisher: John Wiley and Sons
Year: 2001
Weight: 32 KB
Volume: 32
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200113139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Synthesis of Novel

ChemInform Abstract: Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M2 Muscarinic Receptor Antagonists. Part 2.

✍ T. WATANABE; A. KAKEFUDA; I. KINOYAMA; K. TAKIZAWA; S. HIRANO; H. SHIBATA; I. YA 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 2 views

Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M 2 Muscarinic Receptor Antagonists. Part 2. -Among the screened compounds derivative (IIIe) exhibits the highest affinity for M 2 muscarinic receptors and (III

ChemInform Abstract: Discovery of (R)-1-

ChemInform Abstract: Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl] -4-(4-methyl-benzyl)-piperidin-4-ol: A Novel NR1/2B Subtype Selective NMDA Receptor Antagonist.

✍ Emmanuel Pinard; Alexander Alanine; Anne Bourson; Bernd Buettelmann; Ramanjit Gi 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 38 KB 👁 1 views

ChemInform Abstract: Synthesis of Novel

ChemInform Abstract: Synthesis of Novel Succinamide Derivatives Having the 5,11-Dihydro-6H- pyrido(2,3-b)(1,4)benzodiazepin-6-one Skeleton as Potent and Selective M2 Muscarinic Receptor Antagonists. Part 1.

✍ T. WATANABE; I. KINOYAMA; A. KAKEFUDA; T. OKAZAKI; K. TAKIZAWA; S. HIRANO; H. SH 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of trans-N-[4- [2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl] -4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat.

✍ Geoffrey Stemp; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 1 views